FWL Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

FWL Investment Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.32K	Hold	84	–	–	﹤0.01%	320
2026 Q1	$7.28K	Hold	84	–	–	﹤0.01%	274
2025 Q4	$7.13K	Hold	84	–	–	﹤0.01%	295
2025 Q3	$6.09K	Hold	84	–	–	﹤0.01%	285
2025 Q2	$5.5K	Sell	84 -96	-53%	-$6.25K	﹤0.01%	262
2025 Q1	$12.7K	Hold	180	–	–	﹤0.01%	213
2024 Q4	$11.8K	Hold	180	–	–	﹤0.01%	232
2024 Q3	$12.7K	Buy	+180	New	+$12.5K	﹤0.01%	222

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

FWL Investment Management's IHE Position: Q2 2026 in Review

FWL Investment Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 84 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

FWL Investment Management first reported a position in IHE in Q3 2024 and has held it in 8 quarters since. The position peaked at $12.7K in Q3 2024. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

FWL Investment Management held 84 shares of iShares US Pharmaceuticals ETF worth $8.32K as of Q2 2026.
FWL Investment Management left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of FWL Investment Management's portfolio in Q2 2026, its #320 holding.
FWL Investment Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and has held it in 8 quarters since.
FWL Investment Management's iShares US Pharmaceuticals ETF position peaked at $12.7K in Q3 2024.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.